Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-016727
Filing Date
2020-02-11
Accepted
2020-02-11 17:07:18
Documents
1
Period of Report
2020-02-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm207617d1_4.html 4  
1 OWNERSHIP DOCUMENT tm207617d1_4.xml 4 7736
  Complete submission text file 0001104659-20-016727.txt   9705
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Reporting) CIK: 0001425738 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39208 | Film No.: 20597988

Mailing Address ONE LETTERMAN DRIVE, BUILDING D SUITE D3-300 SAN FRANCISCO CA 94129
Business Address
Green Jeremy (Reporting) CIK: 0001650527 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39208 | Film No.: 20597989

Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Issuer) CIK: 0001745999 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)